Evidence map›Paper›PMID 35418097›Full record

ArticleArchives of public health = Archives belges de sante publique2022

COVID-19 contact tracing in Belgium: main indicators and performance, January - September 2021.

Kristiaan Proesmans, Sharon Hancart, Toon Braeye, Sofieke Klamer, Emmanuel Robesyn, Achille Djiena, Frances De Leeuw, Romain Mahieu, Alex Dreuw, Naima Hammami and 3 more

Open access · goldAbstract read
In one paragraph

Article in Archives of public health = Archives belges de sante publique, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Kristiaan ProesmansDepartment of Epidemiology and public health, Sciensano, Brussels, Belgium. kristiaan.proesmans@sciensano.be.ORCID http://orcid.org/0000-0002-7787-9397
Sharon HancartDepartment of Epidemiology and public health, Sciensano, Brussels, Belgium.
Toon BraeyeDepartment of Epidemiology and public health, Sciensano, Brussels, Belgium.
Sofieke KlamerDepartment of Epidemiology and public health, Sciensano, Brussels, Belgium.
Emmanuel RobesynEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Achille DjienaAgence pour une Vie de Qualité, Charleroi, Belgium.
Frances De LeeuwDepartment of Infectious Disease Prevention and Control, Common Community Commission, Brussels-Capital Region, Brussels, Belgium.
Romain MahieuDepartment of Infectious Disease Prevention and Control, Common Community Commission, Brussels-Capital Region, Brussels, Belgium.
Alex DreuwMinistry of the German-speaking Community, Eupen, Belgium.
Naima HammamiAgency for Care and Health, Infection Prevention and Control, Flemish Community, Brussels, Belgium.
Dirk WildemeerschAgency for Care and Health, Infection Prevention and Control, Flemish Community, Brussels, Belgium.
Laura CornelissenDepartment of Epidemiology and public health, Sciensano, Brussels, Belgium.
Dieter Van CauterenDepartment of Epidemiology and public health, Sciensano, Brussels, Belgium.
Sciensano (Belgium) · BECommon Community Commission · BEFlemish Community · BEEuropean Centre for Disease Prevention and Control · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundContact tracing is one of the main public health tools in the control of coronavirus disease 2019 (COVID-19). A centralized contact tracing system was developed in Belgium in 2020. We aim to evaluate the performance and describe the results, between January 01, 2021, and September 30, 2021. The characteristics of COVID-19 cases and the impact of COVID-19 vaccination on testing and tracing are also described.

methodsWe combined laboratory diagnostic test data (molecular and antigen test), vaccination data, and contact tracing data. A descriptive analysis was done to evaluate the performance of contact tracing and describe insights into the epidemiology of COVID-19 by contact tracing.

resultsBetween January and September 2021, 555.181 COVID-19 cases were reported to the central contact center and 91% were contacted. The average delay between symptom onset and contact tracing initiation was around 5 days, of which 4 days corresponded to pre-testing delay. High-Risk Contacts (HRC) were reported by 49% of the contacted index cases. The mean number of reported HRC was 2.7. In total, 666.869 HRC were reported of which 91% were successfully contacted and 89% of these were tested at least once following the interview. The estimated average secondary attack rate (SAR) among the contacts of the COVID-19 cases who reported at least one contact, was 27% and was significantly higher among household HRC. The proportion of COVID-19 cases who were previously identified as HRC within the central system was 24%.

conclusionsThe contact-tracing system contacted more than 90% of the reported COVID-19 cases and their HRC. This proportion remained stable between January 1 2021 and September 30 2021 despite an increase in cases in March-April 2021. We report high SAR, indicating that through contact tracing a large number of infections were prospectively detected. The system can be further improved by (1) reducing the delay between onset of illness and medical consultation (2) having more exhaustive reporting of HRC by the COVID-19 case.

Indexed as

BelgiumContact tracingCOVID-19

Identifiers

PMID35418097
PMCPMC9005619
OpenAlexW4225962435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.